To assess the efficacy of itolizumab versus placebo as initial therapy for aGVHD in combination with corticosteroids in achieving early disease response.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Katarzyna Jamieson
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Leukemia, Lymphoma)
22-0833
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
